Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
31.94
-0.56 (-1.72%)
At close: Jul 6, 2026, 4:00 PM EDT
31.96
+0.02 (0.06%)
After-hours: Jul 6, 2026, 5:05 PM EDT
Immunocore Holdings Market Cap
Immunocore Holdings has a market cap or net worth of $1.62 billion as of July 6, 2026. Its market cap has increased by 2.02% in one year.
Market Cap
1.62B
Enterprise Value
1.22B
1-Year Change
2.02%
Ranking
Category
Stock Price
$31.94
Market Cap Chart
Since February 5, 2021, Immunocore Holdings's market cap has decreased from $1.80B to $1.62B, a decrease of -9.54%. That is a compound annual growth rate of -1.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 1.62B | -7.37% |
| Dec 31, 2025 | 1.75B | 18.83% |
| Dec 31, 2024 | 1.48B | -56.30% |
| Dec 29, 2023 | 3.38B | 23.54% |
| Dec 30, 2022 | 2.73B | 82.12% |
| Dec 31, 2021 | 1.50B | -16.41% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Maze Therapeutics | 1.73B |
| Ascentage Pharma Group International | 1.72B |
| Zenas BioPharma | 1.72B |
| Vir Biotechnology | 1.69B |
| MapLight Therapeutics | 1.68B |
| Innoviva | 1.65B |
| Fortrea Holdings | 1.63B |
| ArriVent BioPharma | 1.61B |